← Back to headlines
Ketamine-Derived Drug Becomes J&J Blockbuster
A drug developed from ketamine has reportedly become a $1.7 billion blockbuster for Johnson & Johnson, highlighting its significant market success.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
